# A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program

> **NCT07429942** · — · NOT_YET_RECRUITING · sponsor: **Takeda** · enrollment: 94 (estimated)

## Conditions studied

- Thrombotic Thrombocytopenic Purpura (TTP)

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT07429942
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-31
- **Primary completion:** 2026-07-06
- **Final completion:** 2026-07-06
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2026-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07429942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07429942, "A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT07429942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*